Octagon Capital

Funding rounds backed by Octagon Capital.

Export CSV
Funding disclosed in full
$90M
Median round
$90M
Rounds in calculation
1
1 round
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Epicrispr Biotechnologies

Develops programmable epigenetic medicines to treat genetic diseases like FSHD

$90MSeries CBiotechUnited States
9 participantsabrdnAngelini VenturesCormorant Asset ManagementDuquesne Family OfficeFidelity Management & Research CompanyJanus Henderson InvestorsOctagon CapitalReadout CapitalSanofi Ventures